disease Waldenström macroglobulinemia in first relapse or with primary refractory of cyclophosphamide-doxorubicin-prednisone in 92 patients with Multicenter, randomized comparative trial of fludarabine and the combination

Bernard Desablens, Francois Guilhot, Guilaine Philippe, Aspasia Stamatoullas and Odile Guibon Harousseau, Liliane Remenieras, Raphael Porcher, Martine Gardembas, Gerald Marit, Eric Deconinck, Veronique Leblond, Vincent Levy, Frederic Maloisel, Bruno Cazin, Jean-Paul Fermand, Jean-Luc disease Waldenstrom macroglobulinemia in first relapse or with primary refractory of cyclophosphamide-doxorubicin-prednisone in 92 patients with Multicenter, randomized comparative trial of fludarabine and the combination

[1]  J. Waldenström.  Incipient myelomatosis or «essential« hyperglobulinemia with fibrinogenopenia — a new syndrome? , 2009 .

[2]  R. Porcher,et al.  Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis , 2001, Leukemia.

[3]  B. Cheson,et al.  Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. , 2000, The New England journal of medicine.

[4]  M. Błasińska-Morawiec,et al.  Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial. , 2000, Blood.

[5]  B. Grosbois,et al.  patients with the description of a new scoring system and its validation on 253 other patients. , 2000, Blood.

[6]  M. Dimopoulos,et al.  Waldenström's macroglobulinemia: clinical features, complications, and management. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  R. Weide,et al.  Induction of complete haematological remission after monotherapy with anti-CD20 monoclonal antibody (RITUXIMAB) in a patient with alkylating agent resistant Waldenström's macroglobulinaemia. , 1999, Leukemia & lymphoma.

[8]  Sy Yang,et al.  Autologous peripheral blood stem cell transplantation for Waldenstrom’s macroglobulinemia , 1999, Bone Marrow Transplantation.

[9]  B. Freidlin,et al.  Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  N. Schmitz,et al.  Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenström's macroglobulinaemia , 1999, British journal of haematology.

[11]  J. Zaucha,et al.  Effect of a 2‐hour infusion of 2‐chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia , 1999, European journal of haematology.

[12]  B. Barlogie,et al.  High‐dose therapy with autologous haemopoietic stem cell support for Waldenström's macroglobulinaemia , 1999, British journal of haematology.

[13]  B. Coiffier,et al.  Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Dimopoulos,et al.  Waldenström's macroglobulinemia. , 1994, Hematology/oncology clinics of North America.

[15]  A. Saven,et al.  Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia , 1998, British journal of haematology.

[16]  I. Yakoub-Agha,et al.  Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Kimura,et al.  Durable remission after splenectomy for Waldenström's macroglobulinemia with massive splenomegaly in leukemic phase. , 1997, Leukemia & lymphoma.

[18]  A. Chott,et al.  First-line treatment of Waldenström's disease with cladribine , 1997, Annals of Hematology.

[19]  J. Humphrey,et al.  Durable complete remission of macroglobulinemia after splenectomy: A report of two cases and review of the literature , 1995, American journal of hematology.

[20]  F. Gherlinzoni,et al.  Fludarabine treatment in resistant Waldenstrom's macroglobulinemia , 1995, European journal of haematology.

[21]  M. Dimopoulos,et al.  Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  E. Estey,et al.  Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[24]  A. Delannoy,et al.  2-Chlorodeoxyadenosine therapy in Waldenstrom's macroglobulinaemia. , 1994, Nouvelle revue francaise d'hematologie.

[25]  P. Gobbi,et al.  Study of prognosis in Waldenström's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility. , 1994, Blood.

[26]  E. Iannitto,et al.  A Phase II Trial on Alpha-Interferon α IFN) Effect in Patients with Monoclonal IgM Gammopathy , 1994 .

[27]  J. Binet.  Is the CHOP regimen a good treatment for advanced CLL? Results from two randomized clinical trials. French Cooperative Group on Chronic Lymphocytic Leukemia. , 1994, Leukemia & lymphoma.

[28]  A. Duhamel,et al.  Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  B. Barlogie,et al.  Fludarabine therapy in Waldenström's macroglobulinemia. , 1993, The American journal of medicine.

[30]  H. Kantarjian,et al.  Treatment of Waldenstrom Macroglobulinemia with 2-Chlorodeoxyadenosine , 1993, Annals of Internal Medicine.

[31]  D. Redfield,et al.  Waldenström's macroglobulinemia: long-term results with the M-2 protocol. , 1991, Cancer investigation.

[32]  R. Kurzrock,et al.  Fludarabine therapy in macroglobulinemic lymphoma. , 1990, Blood.

[33]  F. Mandelli,et al.  Waldenström's macroglobulinaemia: results of a combined oral treatment in 34 newly diagnosed patients , 1989, Journal of internal medicine.

[34]  B. Barlogie,et al.  Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemia , 1988, American journal of hematology.

[35]  G. Clamon,et al.  Successful doxorubicin therapy of primary macroglobulinemia resistant to alkylating agents , 1980, American journal of hematology.

[36]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .